Cheniere Energy Inc.

---

step: 01 title: Business Model / Overview source: coverage-next-full ticker: LNG company: Cheniere Energy, Inc. created: 2026-05-28

Step 01 — Business Model

Key Findings

• Net positive for thesis. Cheniere operates the largest LNG export franchise in the US (~52 mtpa operating, ~30%+ US share) [S1] with tolling-style economics on ~95% contracted capacity [S2].
• Revenue economics: SPA fixed fees (~$2.50-3.00/MMBtu margin estimate) + variable cost pass-through + IPM gross-margin + marketing/spot uplift on ~5% [S2].
• Two terminals (Sabine Pass LA + Corpus Christi TX), one fungible commercial book via CMI marketing arm [S1].
• C-Corp parent structure makes LNG the institutional-friendly vehicle vs. K-1-issuing CQP MLP.

Implications for Thesis and Valuation

• The economic shape is tolling/infrastructure with embedded commodity optionality — supports DCF valuation anchored on contracted run-rate, with optionality value on uncontracted spot + new expansion FIDs.
• Long contract ladder (~15+ years avg remaining) provides cash flow visibility through 2040s [S2].
• Brownfield expansion advantage at Corpus Christi (existing land + pipeline + storage + permits) drives lower marginal capex per mtpa than greenfield US competitors [S3].

Objective

Articulate exactly how LNG makes money, the unit economics of an LNG cargo, and the value-chain layers in which Cheniere participates.

Narrative Analysis

What LNG sells: Liquefied natural gas (LNG), produced by chilling pipeline natural gas to -260°F at coastal liquefaction trains, loaded onto LNG carriers, and delivered to international buyers (primarily Europe, Asia) [S1]. Cheniere is purely an LNG export business — no upstream production, no downstream import/regasification, no power generation [S1].

Who buys: ~95% of operating capacity is sold under long-term Sale and Purchase Agreements (SPAs) to ~20+ counterparties [S2]: Shell, BG (Shell legacy), Korea Gas (KOGAS), GAIL India, Engie, Centrica, Pertamina, Vitol, BP, TotalEnergies, Naturgy, Equinor, Petronet LNG, JERA, EnBW, Equinor, PTT Global, etc. [S2]. SPAs are typically 20-year take-or-pay structures.

SPA economics: Buyer pays a fixed monthly capacity fee for the right to lift LNG plus a variable fee = 115% × Henry Hub × MMBtu lifted + a fixed differential ($2.25-3.50/MMBtu range) [S2]. The fixed fee is paid whether or not the buyer lifts; the variable fee covers Cheniere's feed gas + transportation + a margin. Result: Cheniere is largely insulated from Henry Hub volatility on contracted volumes (it's a pass-through), but capture the spread between US gas and international LNG on the IPM and marketing/spot portions [S2].

IPM (Integrated Production Marketing): Cheniere directly procures natural gas from US producers (long-term gas purchase agreements), feeds it through the trains, and sells LNG into the international market. The economic spread is wider than SPA-on-Henry-Hub but Cheniere takes commodity-price risk on both legs [S4].

Marketing/spot: Cheniere Marketing Inc (CMI) handles uncontracted volumes — the ~5% gap between nameplate capacity and contracted volumes plus any excess from production overperformance. In high-spread environments (e.g., 2022 post-Ukraine), this segment generated huge windfalls. In oversupplied environments (likely 2027-2030), spreads compress [S4].

Asset base:

• Sabine Pass (LA): 6 operational liquefaction Trains, ~30 mtpa nameplate, owned via CQP MLP (LNG owns 48.6% LP + 100% GP) [S1]
• Corpus Christi (TX): 3 operational Stage 1-2 Trains (~15 mtpa) + Stage 3 ramping (7 midscale trains, ~10 mtpa) + Midscale 8-9 (~5 mtpa, FID June 2025, 2H 2028 target) [S1][S5]
• In permitting: SPL Expansion (~20 mtpa, FERC + DOE pending) + CCL Stage 4 (~3 mtpa, early planning) [S5]

Value-chain layer map:

Layer	Cheniere's role	Captured?
Upstream gas production	No — buys from producers	No
Gas gathering / processing	Partial — own pipelines into terminals	Yes, infrastructure tolling
Liquefaction	Core	Yes — primary economic engine
LNG shipping	Minimal — typically FOB sale; CMI optimizes	Partial (CMI chartering)
Regasification (import)	No	No
Power gen / distribution	No	No

Secondary track noted: Pipeline + storage + commercial book gives partial infrastructure characteristics, but the dominant economic engine is LNG export tolling. Per sector-tracks.md guidance for multi-track companies, primary = Commodity/Upstream; secondary = Infrastructure. Documented here.

Why this matters: The tolling-style fixed-fee structure (long-duration SPAs) creates substantial cash flow visibility — closer to a midstream/pipeline business than to a typical commodity E&P. The economic optionality lies in: (1) the uncontracted ~5%, (2) re-contracting of SPAs as legacy contracts mature, (3) new expansion capacity FIDs (Midscale 8-9 already FID'd; Stage 4 + SPL Expansion in development).

Evidence and Sources

• 10-K FY2024 (LNG_financials/sec_filings/10K_FY2024_summary.md): contract architecture, terminal capacity
• 10-K FY2025 summary: capacity update + Midscale 8-9 FID
• Investor presentation FY25 4Q: visualizes contract book and capacity ramp

Assumption Register Updates

• A02: ~95% contracted (Fact, High sensitivity)
• A03: ~15+ years avg remaining SPA life (Fact, High)
• A04: SPA fixed fee margin ~$2.50-3.00/MMBtu (Estimate, High)

Tables and Calculations

Capacity Ladder (mtpa nameplate)

Asset	Status	Capacity (mtpa)	Sub	Substantial completion
SPL Trains 1-6	Operating	~30	CQP / SPL	2016-2019
CCL Stage 1-2 (Trains 1-3)	Operating	~15	CCH	2018-2019
CCL Stage 3 (Trains 1-7)	Train 1 done 2024; ramping	~10	CCH	2025-2026
CCL Midscale 8-9	Under construction	~5	CCH	2H 2028 (FID Jun 2025)
SPL Expansion	Permitting	~20	SPL/new	TBD
CCL Stage 4	Early planning	~3	CCH	TBD
Total operational potential		~83		by ~2030

Revenue Economics by Channel (run-rate estimate)

Channel	% of revenue	Key driver	Sensitivity to HH	Sensitivity to JKM/TTF
SPA fixed	~25-30%	Capacity reserved	None (pass-through)	None
SPA variable	~50-55%	115% × HH	Pass-through	None
IPM	~10-15%	Producer gas + LNG sale	Direct (own gas leg)	Direct
Marketing/spot	~5-10%	Spot LNG margin	Direct	Direct

(Mix shifts toward variable/IPM in high-HH years; toward marketing in high-spread years.)

Open Questions and Data Gaps

• Counterparty-specific SPA pricing not publicly disclosed — Step 03 will model blended.
• Stage 4 FID timing → potential optionality but not in base case.
• SPL Expansion DOE non-FTA approval risk — political timing uncertain.

Next-Step Dependencies

Step 02 will reuse industry/market_overview.md and competitive_landscape.md to size end-market and assess competitive intensity. Step 03 will reuse this channel framework.

Source Index

Tag	Document / URL	Section	Date	Notes
[S1]	LNG 10-K FY2024 + FY2025	Business overview	2025/2026	Capacity, terminal locations
[S2]	LNG 10-K FY2024	Customer contracts	2025-02	SPA structure
[S3]	Investor presentation FY25 4Q	Capital allocation + capacity	2026-02-26	LNG_financials/presentations
[S4]	LNG 10-K FY2025	Marketing / IPM	2026-02	Channel economics
[S5]	LNG press release June 18, 2025	CCL Midscale 8-9 FID	2025-06	sec_filings

---

step: 04 title: Financial Quality & Adversarial Sweep source: coverage-next-full ticker: LNG company: Cheniere Energy, Inc. created: 2026-05-28

Step 04 — Financial Quality

Key Findings

• Net positive for thesis (with caveats). Underlying economic earnings (Adj EBITDA, DCF) are stable and rising; GAAP earnings are noisy due to large derivative MTM swings that are non-cash [S1].
• No revenue-recognition red flags. ASC 842 lease accounting and ASC 606 SPA recognition are standard and consistent with peer practice [S2].
• Adversarial sweep: no active short-seller reports of consequence; no SEC investigation; routine operating litigation only. No accounting scandals in company history [S3].
• Working capital negative in 1Q26 ($-3.1B) reflects MTM derivative liability spike; not operational distress.

Implications for Thesis and Valuation

• Use Adj EBITDA + DCF as primary valuation inputs; treat GAAP EPS as secondary/noisy.
• Normalize 1Q26 GAAP loss via adjusted EPS reconciliation in MD&A — actual cash economics intact.
• Free cash flow has compressed FY2024-2025 due to peak Stage 3 capex; ramps after 2026 as capex normalizes to ~$1-1.5B maintenance level.

Objective

Assess earnings quality (cash vs. accrual), identify any accounting red flags, complete the adversarial sweep (short reports, investigations, litigation), and confirm financial statements can be trusted as the basis for valuation.

Narrative Analysis

Earnings quality: Cheniere's reported GAAP net income is highly volatile (FY2021 -$2.3B, FY2022 $1.4B, FY2023 $9.9B, FY2024 $3.3B, FY2025 $5.3B, 1Q26 -$3.5B) [S1]. The volatility is not driven by operating cash economics but by derivative mark-to-market accounting: Cheniere has substantial hedge positions on Henry Hub feed gas and on certain SPA fair-value designations. When Henry Hub or international spot prices move sharply, the derivative book gets repriced through P&L, generating non-cash gains or losses that don't reflect underlying business performance [S1].

The "right" lens is Consolidated Adjusted EBITDA (the company's primary disclosed metric) and Distributable Cash Flow (DCF) [S2]. Both strip MTM volatility and exclude SBC; they reflect the cash spreadable to debt service, dividends, and buybacks. Adj EBITDA trajectory:

• FY2022 $11.7B (spike, post-Ukraine spot windfall)
• FY2023 $8.8B (normalization but still elevated spread)
• FY2024 $6.2B (further normalization)
• FY2025 ~$7.0B (Stage 3 Train 1 contribution + better realized pricing)
• FY2026 guidance $7.25-7.75B (raised twice during the year)

DCF trajectory similar: $8.6B → $6.5B → $3.7B → $4.6B → $4.75-5.25B guide.

The takeaway: operating cash economics have been stable-to-rising even as GAAP EPS swings. The 1Q26 GAAP loss of $3.5B was paired with adjusted EPS of $4.77 — a beat versus consensus $3.91 [S2].

Revenue recognition: SPA take-or-pay revenue is recognized over the period the buyer has the right to lift (ASC 606); marketing/spot recognized at delivery. Pipeline tolling recognized over service period. No aggressive front-loading or bill-and-hold issues evident in 10-K footnote disclosures [S2].

Balance sheet integrity: Total debt ~$25.5B is mostly project-level non-recourse at SPL (CQP sub) and CCH levels, with parent-level debt minimal — investment-grade rated [S2]. The negative book equity in FY2022 (-$171M) was an AOCL artifact from MTM hedge liabilities; resolved as hedges rolled off, equity now $13B [S1].

Capex and FCF quality: Capex has risen with the Stage 3 + Midscale 8-9 build cycle (FY21 $966M → FY25 $3,078M). Free cash flow compressed in FY24-25 because of peak growth capex but remains positive [S1]. Normalized maintenance capex is closer to $0.8-1.0B/year; expansion capex will continue through 2028 (Midscale 8-9 buildout).

SBC dilution: ~$130-160M/year in SBC, small relative to FCF and offset many times over by ~$2.5-2.8B/year buybacks.

Adversarial Research Sweep

Short reports: Tavily search surfaced no recent material short-seller reports targeting Cheniere. Short interest is low: 4.31M shares (~2% of float) per StockAnalysis.com [S4]. No Hindenburg / Muddy Waters / Kerrisdale exposes found.

SEC/DOJ investigations: No active investigations of note. The company has routine SEC comment letters typical of large issuers; nothing involving accounting restatements [S3].

Litigation: Routine: gas supply contract disputes, environmental permitting opposition, employment matters. No outsized contingent liability disclosed in 10-K MD&A [S3]. Notable: Venture Global (competitor) has been sued by major counterparties (Shell, BP, Repsol) over LNG delivery delays — this is a competitive risk benefit to Cheniere (highlights its execution advantage), not a Cheniere risk.

Accounting concerns: No restatements in last 5 years. KPMG audit opinion clean. ICFR effective per 10-K Item 9A.

Insider activity (Q4 2025 / Q1 2026): CFO Davis sold 29K @ ~$300 (likely 10b5-1); routine director RSU grants. No insider buying, no clustering of sales that would suggest insider concern [S5]. Net signal: neutral.

Hedge book complexity: This is the one area requiring attention. Cheniere uses commodity derivatives (gas, LNG, FX, interest rate). The notional book is large and disclosure is technical. Investors should:

1. Track derivative MTM impact in EPS reconciliation
2. Watch the AOCL line on balance sheet
3. Rely on Adj EBITDA, not GAAP NI, for run-rate

This is a valid concern for valuation methodology but does NOT indicate financial misconduct — it's the price of operating a commodity-tolling business that hedges contractual exposures.

Evidence and Sources

LNG_financials/xbrl/xbrl_summary.md, 10-K summaries, stockanalysis_summary.md.

Assumption Register Updates

• A05 (reinforced): Adj EBITDA reflects underlying economics; GAAP NI distorted by derivative MTM (Judgment, High)

Tables and Calculations

Earnings Quality — GAAP vs Adj (USD M)

Year	GAAP NI	Adj EBITDA	DCF	Comment
2021	(2,343)	~5,500	n/a	Hedge MTM loss
2022	1,428	~11,650	~8,650	Hedge MTM offset gains; pure cash strong
2023	9,881	~8,800	~6,500	Hedge gains accelerated GAAP
2024	3,252	6,162	3,720	Normalized
2025	5,330	~7,030	~4,640	Stage 3 Train 1
1Q26	(3,502)	~$1.9B (est)	~$1.4B (est)	GAAP loss, adj EPS +22% beat

Free Cash Flow & Capital Discipline (USD M)

Year	OCF	Capex	FCF	Buybacks	Dividends	Net Debt Δ
2021	2,469	(966)	1,503	(57)	(85)	-899 (paydown)
2022	10,523	(1,830)	8,693	(1,436)	(349)	-5,196 (paydown)
2023	8,418	(2,121)	6,297	(1,536)	(393)	-1,201 (paydown)
2024	5,394	(2,238)	3,156	(2,308)	(412)	-796 (paydown)
2025	5,539	(3,078)	2,461	(2,775)	(451)	-105 (paydown)

Pattern: aggressive debt paydown 2022-2024 then pivot to capital return at constant balance sheet.

Adversarial Sweep Scorecard

Vector	Status	Severity
Short-seller report	None active	N/A
SEC/DOJ investigation	None	N/A
Class-action litigation	None material	N/A
Accounting restatement	None (5y)	N/A
Auditor opinion	Clean (KPMG)	N/A
Insider clustering	None	Low
Hedge MTM complexity	Real but legitimate	Med (use Adj metrics)
Counterparty disputes	Counterparties suing VG, not LNG	Positive read

Open Questions and Data Gaps

• Detailed derivative book composition (Henry Hub forward curve assumption sensitivity) — only summary disclosure in 10-K.
• Exact tax sheltering from CQP MLP structure flow-through — handled in tax note but complex.

Next-Step Dependencies

Step 05 will reuse Adj EBITDA + DCF run-rate trajectory for quarterly momentum lens.

Source Index

Tag	Document / URL	Section	Date	Notes
[S1]	xbrl_summary.md	Income statement + balance sheet history	2026-05-28	StockAnalysis aggregation
[S2]	LNG 10-K FY2024 + FY2025	Revenue recognition, Adj EBITDA reconciliation	2025-2026	10K summaries
[S3]	LNG 10-K FY2024 Item 1A + 3	Risk factors + legal proceedings	2025-02	10K_FY2024_summary.md
[S4]	StockAnalysis.com statistics	Short interest	2026-05-28	stockanalysis_summary.md
[S5]	secform4 / stocktitan Form 4 sweep	Q4 2025 - Q1 2026	2026-05-28	insider_transactions.md
[S6]	Reuters/Bloomberg coverage of VG litigation	Shell, BP, Repsol vs VG	2024-2025	media coverage

---

step: 12 title: Catalysts & Variant Perception Setup source: coverage-next-full ticker: LNG company: Cheniere Energy, Inc. created: 2026-05-28

Step 12 — Catalysts & Variant Perception Setup

Key Findings

• Net positive for thesis. The near-term catalyst roadmap is the richest in the energy sector: 3-4 distinct value-unlocking events across FY2026-FY2028 provide multiple "shots on goal" for a re-rating [S1][S2].
• The defining debate is whether the market prices LNG as a commodity company (8-10x EV/EBITDA) or as infrastructure (13-15x). Each Stage 3 completion, guidance raise, and buyback milestone is evidence for the infrastructure re-rating thesis [S3].
• The negative catalysts (LNG glut realization, DOE policy risk) are delayed and largely already in sell-side models — upside surprises from execution are more likely than downside surprises from known risks [S2][S3].

Implications for Thesis and Valuation

• Catalyst density means the holding period for maximum risk-adjusted return is 12-24 months: Stage 3 Train 4-7 completions (2026) + 2026 guidance beat + possible Stage 4 FID = multiple events compressing between now and YE 2026.
• Stage 4 FID would be the largest single re-rating catalyst: adds ~3 mtpa and signals Cheniere is returning to growth mode post-Midscale 8-9.
• SPL Expansion DOE authorization is a long-dated option: every year it goes unresolved is a neutral; the day it is received is an immediate NAV step-up.

Objective

Identify discrete catalysts (positive and negative), estimate timing and magnitude, and set up the bull/bear case structure for /complete-coverage valuation work.

Narrative Analysis

Positive Catalysts

1. Corpus Christi Stage 3 Trains 4-7 substantial completion (FY2026)

• What: Trains 4-7 of the Stage 3 Project (~7 mtpa total) ramping through 2026. Management guided for all 7 trains completed by YE2026 [S1].
• Why it matters: Each train adds ~$150-250M incremental Adj EBITDA at steady state. Four trains ramped = +$600M-$1.0B incremental run-rate.
• Timing: Phased through CY2026; Train 4 earliest (1H), Train 7 latest (4Q 2026 or 1H 2027).
• Market impact: Every on-schedule substantial completion is a guidance beat setup and confirms the DCF/share ramp story. Incremental guide raises likely at each quarterly earnings.

2. FY2026 Guidance Beats / Raises (ongoing)

• What: Management has raised 2026 EBITDA guidance twice already ($6.75B → $7.25B → $7.25-7.75B). Pattern suggests continued upward revision if Stage 3 ramp proceeds.
• Why it matters: 23 analysts covering; consensus re-priced higher with each raise. A third raise to $7.5-8.0B would trigger upgrades.
• Timing: Each quarterly earnings (2Q26, 3Q26, 4Q26).

3. CCL Stage 4 FID Decision (2026-2027)

• What: ~3 mtpa additional capacity at Corpus Christi; FID expected 2026-2027. Capex est. $2-3B; Bechtel likely EPC [S1].
• Why it matters: A Stage 4 FID signals Cheniere is not done growing — and adds another $0.5-0.75B run-rate EBITDA. Would push the company toward ~$10B Adj EBITDA run-rate by 2030.
• Timing: 2026 Q3-Q4 or early 2027.
• Market impact: Estimate +$5-10/sh equity value on FID announcement.

4. SPL Expansion DOE Non-FTA Authorization

• What: DOE authorization for SPL Expansion (~20 mtpa potential) is pending. Trump 2.0 administration supportive of LNG exports; authorization likely but timing unclear [S2].
• Why it matters: The authorization unlocks $10B+ of growth capex optionality (~$3-5B equity NAV, assuming project economics hold). FID would follow authorization by 12-18 months.
• Timing: Unknown; possibly 2026.
• Market impact: Likely muted on news alone (markets need FID + SPA book to credit value); but meaningful as a precondition to the next growth leg.

5. $30/Share Run-Rate DCF Validation (FY2027-FY2028)

• What: Management's stated $30/share run-rate DCF post Stage 3 + Midscale 8-9 + buyback compounding. At current $230 stock price, this represents ~7.7x P/DCF — compelling if the $30 figure is achievable [S1].
• Why it matters: When analysts can point to $30/sh actual reported DCF (expected ~FY2027-FY2028), the stock becomes undeniably cheap on a P/DCF basis and should re-rate.
• Timing: FY2027 earnings (February 2028); DCF/share numbers should approach $30+ as buybacks continue and Stage 3 fully ramps.

6. New Long-Term SPA Signings

• What: Cheniere signed 4 new long-term SPAs in FY2025. Additional signings in FY2026 would validate demand for incremental capacity post-Stage 4/SPL Expansion.
• Why it matters: Every new 20-year SPA signed is a long-dated contracted cash flow added; de-risks expansion FID decisions.
• Timing: Continuous; announced in quarterly press releases.

Negative Catalysts

1. LNG Glut Arrives Earlier / Deeper Than Expected (2027-2028)

• What: Venture Global Plaquemines completing + Qatar North Field East surprising to the upside → spot JKM/TTF price collapses to $7-8/MMBtu by 2027.
• Why it matters: Marketing margin compresses; new SPA pricing for Stage 4/SPL Expansion becomes adverse; equity multiple compresses as growth thesis weakens.
• Timing: 2027 spot market data.
• Market impact: -$20-40/sh in a severe glut scenario; equity multiple could fall to 8-9x from 12x.

2. DOE Non-FTA Authorization Delay or Reversal

• What: A policy change at DOE (new administration or executive action) pauses or restricts LNG export authorizations, delaying Stage 4 FID or SPL Expansion.
• Why it matters: Caps growth at ~$8-9B run-rate EBITDA; eliminates $3-5B option value from equity.
• Timing: Election cycle; any major political shift.
• Market impact: -$10-20/sh on a delay; more on a hard cap scenario.

3. Stage 3 Completion Delay or Cost Overrun

• What: One or more Trains 4-7 miss YE2026 substantial completion deadline, pushing incremental EBITDA into 2027.
• Why it matters: Guidance misses; sentiment turns negative; multiple compression.
• Timing: Quarterly updates beginning 2Q26.
• Market impact: -$5-15/sh per quarter of delay; manageable if contained.

4. Henry Hub Feed Gas Spike (>$7/MMBtu sustained)

• What: Supply disruption (hurricane, severe winter) pushing HH above $7/MMBtu for multiple quarters.
• Why it matters: Marketing margin collapses; uncontracted volumes economics turn negative; public perception of risk spikes.
• Timing: Seasonal (winter); hurricane season (June-November).
• Market impact: -$5-10/sh in severe spike; temporary.

Variant Perception Setup

The core variant perception for /complete-coverage:

• Market view: Cheniere is a commodity-exposed LNG company trading at 12x EV/EBITDA with modest upside to ~14x.
• Variant view: At ~$230/sh and ~9x P/FY2027 DCF, the market is pricing a commodity multiple on what is effectively an infrastructure business with 15-year contracted cash flows and a $30/sh DCF ramp that is NOT priced in. The buyback compounding math compounds the discount — each year of buybacks at $230/sh is deeply value-accretive if NAV is $290-340.
• Variant trigger: The market will have to re-rate when reported FY2027 DCF/sh approaches $30 and analysts cannot justify a 7-8x P/DCF multiple for an investment-grade infrastructure company.

---

Bull Case

• Stage 3 Trains 4-7 complete on schedule by YE2026, Stage 4 FID taken H1 2027, SPL Expansion DOE authorization received. Run-rate Adj EBITDA reaches $9-10B by FY2028 with Midscale 8-9 and Stage 4 contributing. Buybacks continue at $2.5B/yr, share count falls to ~175-180M by FY2028. DCF/share hits $40-45+ by FY2028-2029. Multiple re-rates to 11-12x P/DCF as the infrastructure narrative dominates. Stock reaches $400-450 within 24-36 months (+75-95% from current $230).

• LNG demand surprises to the upside (China restocking, European structural demand, South/SE Asia FSRU build-out) absorbs the new supply, keeping JKM/TTF spot at $12-15/MMBtu through 2028. Marketing margin stays elevated; new SPA pricing for Stage 4/SPL Expansion is signed at favorable terms. EBITDA beat vs. consensus each quarter.

• Buyback math compounds mechanically. At $2.5B/yr on a $48B market cap with $4.75-5.25B DCF guide: management effectively returning >50% of DCF/yr to shareholders. In 3 years, this alone justifies a $50-70/sh stock move on pure payout math even without multiple expansion.

Bear Case

• LNG global supply glut arrives harder than expected in 2027. Venture Global Plaquemines + NextDecade Rio Grande Phase 1 + Qatar North Field East + Canada LNG all reach full output in 2026-2027. JKM spot falls below $9/MMBtu; new SPA buyers demand fixed fees $0.50-1.00/MMBtu lower than legacy book. Stage 4 and SPL Expansion FID economics fail at the new pricing → both are deferred indefinitely. EBITDA peaks at ~$8B (Stage 3 full ramp) then flattens; growth narrative ends. Multiple compresses to 8-9x EV/EBITDA. Stock falls to $160-180 (-22-30% from current).

• US DOE non-FTA authorization regime changes under a future administration (post-2028 election) that prioritizes domestic gas affordability over exports. Stage 4 and SPL Expansion are blocked or severely delayed. Option value disappears. Free cash flow after Midscale 8-9 is returned to shareholders but growth story is capped. Buyback mechanical support limits downside, but stock stagnates at $200-220 for years.

• Henry Hub feed gas spike (>$7/MMBtu sustained 2+ quarters) coincides with LNG spot price softness, creating a rare scenario where contracted variable fees are elevated (HH pass-through) but spot/marketing margins are compressed (HH cost > JKM net back). IPM economics go underwater. Cheniere cuts marketing volumes, takes modest EBITDA hit, and management credibility suffers from unexpected guidance miss. Stock falls 15-20% intraday on earnings miss; recovers as contracted book is re-underwritten.

---

Evidence and Sources

consensus.md, investor_presentation_2026.md, 10K_FY2025_summary.md, market_overview.md, LNG_thesis_tracker.md.

Assumption Register Updates

• A13 (reinforced): 2027-2030 spot weakness as the bear case hinge
• A14 (reinforced): $30/sh run-rate DCF as the bull case anchor

Tables and Calculations

Catalyst Timeline

Catalyst	Expected Timing	Direction	Magnitude
Stage 3 Train 4-5 completions	H1 2026	Positive	+$5-10/sh
2Q26 earnings — guidance raise	August 2026	Positive	+$5-8/sh
Stage 3 Trains 6-7 completions	H2 2026	Positive	+$5-10/sh
Stage 4 FID	H2 2026 or H1 2027	Positive (large)	+$10-15/sh
SPL Expansion DOE authorization	2026 (uncertain)	Positive (options)	+$5-10/sh
LNG glut data (JKM 2027 forward)	Q1-Q2 2027	Negative risk	-$10-20/sh
$30/sh DCF validation (FY2027 report)	Feb 2028	Positive (large)	Re-rating

Bull / Base / Bear EBITDA Summary

Scenario	FY2027 Adj EBITDA	EV/EBITDA multiple	Implied EV	Implied Equity	$/sh (180M sh)
Bear	$7.5B	9x	$67.5B	$42.5B	~$236
Base	$8.5B	11x	$93.5B	$68.5B	~$381
Bull	$10.0B	13x	$130B	$105B	~$583
Current (2026-05-28)	$7.25-7.75B guide	12.4x	$74.9B	$48.3B	$230

Note: Bear case implies near flat from current; base case +66%; bull case+153%. The asymmetry favors the long position if base case EBITDA delivers.

Open Questions and Data Gaps

• SPA counterparty concentration not fully disclosed; if one major buyer (e.g., KOGAS or GAIL) faces financial stress, the SPA could theoretically be challenged.
• Stage 4 capex estimate: not publicly disclosed; range $2-3B is analyst estimate.
• Political risk timing: DOE authorization/restriction timeline unknown and binary.

Next-Step Dependencies

Step 16 (Variant Perception) builds on the market-vs-variant framing established here. Steps 13/14/15 (in /complete-coverage) execute the DCF and scenario valuation.

Source Index

Tag	Document / URL	Section	Date	Notes
[S1]	investor_presentation_2026.md	Growth pipeline + guidance	2026-02-26	4Q25 earnings deck
[S2]	10K_FY2025_summary.md	Risk factors + growth	2026-02-25	FY25 10-K
[S3]	consensus.md	Analyst consensus + catalysts	2026-05-28	Yahoo/MarketScreener
[S4]	market_overview.md	LNG supply glut data	2026-05-28	IEA/BNEF
[S5]	LNG_thesis_tracker.md	Thesis evolution	2026-05-28	This research package